324 related articles for article (PubMed ID: 12750429)
21. Beta-lyase-dependent attenuation of cisplatin-mediated toxicity by selenocysteine Se-conjugates in renal tubular cell lines.
Rooseboom M; Schaaf G; Commandeur JN; Vermeulen NP; Fink-Gremmels J
J Pharmacol Exp Ther; 2002 Jun; 301(3):884-92. PubMed ID: 12023515
[TBL] [Abstract][Full Text] [Related]
22. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants.
Cooper AJ
Neurochem Int; 2004 Jun; 44(8):557-77. PubMed ID: 15016471
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity.
Hanigan MH; Gallagher BC; Taylor PT; Large MK
Cancer Res; 1994 Nov; 54(22):5925-9. PubMed ID: 7954424
[TBL] [Abstract][Full Text] [Related]
24. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria.
Hayden PJ; Stevens JL
Mol Pharmacol; 1990 Mar; 37(3):468-76. PubMed ID: 2314393
[TBL] [Abstract][Full Text] [Related]
25. Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity.
Lash LH; Nelson RM; Van Dyke RA; Anders MW
Drug Metab Dispos; 1990; 18(1):50-4. PubMed ID: 2139845
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
27. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats.
Sheffels P; Schroeder JL; Altuntas TG; Liggitt HD; Kharasch ED
Chem Res Toxicol; 2004 Sep; 17(9):1177-89. PubMed ID: 15377151
[TBL] [Abstract][Full Text] [Related]
28. Stable transfection of LLC-PK1 cells with human microsomal glutathione S-transferase gene increases haloalkene glutathione S-conjugate formation and cytotoxicity.
Otieno MA; Anders MW
Biochem Biophys Res Commun; 1997 May; 234(2):481-4. PubMed ID: 9177297
[TBL] [Abstract][Full Text] [Related]
29. Nephrotoxicity of the glutathione and cysteine conjugates of 2-bromo-2-chloro-1,1-difluoroethene.
Finkelstein MB; Baggs RB; Anders MW
J Pharmacol Exp Ther; 1992 Jun; 261(3):1248-52. PubMed ID: 1602387
[TBL] [Abstract][Full Text] [Related]
30. Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity.
Townsend DM; Tew KD; He L; King JB; Hanigan MH
Biomed Pharmacother; 2009 Feb; 63(2):79-85. PubMed ID: 18819770
[TBL] [Abstract][Full Text] [Related]
31. Cysteine S-conjugates may act as kidney-selective prodrugs: formation of 6-mercaptopurine by the renal metabolism of S-(6-purinyl)-L-cysteine.
Hwang IY; Elfarra AA
J Pharmacol Exp Ther; 1989 Nov; 251(2):448-54. PubMed ID: 2810108
[TBL] [Abstract][Full Text] [Related]
32. Distribution of cysteine conjugate beta-lyase in gastrointestinal bacteria and in the environment.
Larsen GL
Xenobiotica; 1985 Mar; 15(3):199-209. PubMed ID: 4024656
[TBL] [Abstract][Full Text] [Related]
33. Intranephron distribution of cysteine S-conjugate beta-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats.
Kim HS; Cha SH; Abraham DG; Cooper AJ; Endou H
Arch Toxicol; 1997; 71(3):131-41. PubMed ID: 9049049
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase.
Stevens JL; Hatzinger PB; Hayden PJ
Drug Metab Dispos; 1989; 17(3):297-303. PubMed ID: 2568912
[TBL] [Abstract][Full Text] [Related]
35. Bioactivation of the cysteine-S-conjugate and mercapturic acid of tetrafluoroethylene to acylating reactive intermediates in the rat: dependence of activation and deactivation activities on acetyl coenzyme A availability.
Commandeur JN; De Kanter FJ; Vermeulen NP
Mol Pharmacol; 1989 Oct; 36(4):654-63. PubMed ID: 2811861
[TBL] [Abstract][Full Text] [Related]
36. Cysteine conjugate beta-lyase-catalyzed bioactivation of bromine-containing cysteine S-conjugates: stoichiometry and formation of 2,2-difluoro-3-halothiiranes.
Finkelstein MB; Dekant W; Anders MW
Chem Res Toxicol; 1996; 9(1):227-31. PubMed ID: 8924595
[TBL] [Abstract][Full Text] [Related]
37. Evidence for metabolism of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), a sevoflurane degradation product, by cysteine conjugate beta-lyase.
Spracklin DK; Kharasch ED
Chem Res Toxicol; 1996 Jun; 9(4):696-702. PubMed ID: 8831812
[TBL] [Abstract][Full Text] [Related]
38. Renal cysteine conjugate beta-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells.
Chen JC; Stevens JL; Trifillis AL; Jones TW
Toxicol Appl Pharmacol; 1990 May; 103(3):463-73. PubMed ID: 2339419
[TBL] [Abstract][Full Text] [Related]
39. Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates.
Commandeur JN; King LJ; Koymans L; Vermeulen NP
Chem Res Toxicol; 1996; 9(7):1092-102. PubMed ID: 8902263
[TBL] [Abstract][Full Text] [Related]
40. High pressure liquid chromatography and mass spectrometry characterization of the nephrotoxic biotransformation products of Cisplatin.
Townsend DM; Marto JA; Deng M; Macdonald TJ; Hanigan MH
Drug Metab Dispos; 2003 Jun; 31(6):705-13. PubMed ID: 12756201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
